We are live on ! Find out more
TCA

Trifecta Capital Advisors Portfolio holdings

AUM $646M
1-Year Est. Return 28.42%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+28.42%
3 Year Est. Return
+104.62%
5 Year Est. Return
10 Year Est. Return
AUM
$452M
AUM Growth
+$40.8M
Cap. Flow
+$14.6M
Cap. Flow %
3.23%
Top 10 Hldgs %
49.67%
Holding
434
New
23
Increased
84
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$5.65M
2
LHX icon
L3Harris
LHX
+$2.59M
3
MRK icon
Merck
MRK
+$2.49M
4
PLTR icon
Palantir
PLTR
+$1.86M
5
AMZN icon
Amazon
AMZN
+$1.06M

Sector Composition

Rank Sector Weight
1 Technology 27.55%
2 Healthcare 13.35%
3 Consumer Discretionary 7.7%
4 Communication Services 7.12%
5 Financials 6.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
26
Morgan Stanley
MS
$319B
$5.13M 1.14%
52,749
-355
-0.7% -$33.8K
ABBV icon
27
AbbVie
ABBV
$465B
$5.12M 1.13%
29,835
+1,070
+4% +$177K
UNH icon
28
UnitedHealth
UNH
$382B
$5.12M 1.13%
10,048
+106
+1% +$52K
TJX icon
29
TJX Companies
TJX
$179B
$4.88M 1.08%
44,353
+2,107
+5% +$212K
ADBE icon
30
Adobe
ADBE
$105B
$4.86M 1.08%
8,741
+334
+4% +$162K
ETN icon
31
Eaton
ETN
$141B
$4.73M 1.05%
15,075
+2,261
+18% +$730K
JPM icon
32
JPMorgan Chase
JPM
$916B
$4.69M 1.04%
23,201
+565
+2% +$110K
ISRG icon
33
Intuitive Surgical
ISRG
$127B
$4.68M 1.04%
10,529
+1,296
+14% +$516K
LMT icon
34
Lockheed Martin
LMT
$131B
$4.3M 0.95%
9,202
+913
+11% +$422K
CVX icon
35
Chevron
CVX
$382B
$4.1M 0.91%
26,237
+1,795
+7% +$286K
REGN icon
36
Regeneron Pharmaceuticals
REGN
$72.9B
$3.77M 0.83%
3,583
+285
+9% +$276K
SNPS icon
37
Synopsys
SNPS
$71.6B
$3.75M 0.83%
6,297
+547
+10% +$309K
AMD icon
38
Advanced Micro Devices
AMD
$700B
$3.73M 0.83%
22,984
+2,167
+10% +$349K
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.12T
$3.57M 0.79%
19,581
+1,737
+10% +$293K
IWM icon
40
iShares Russell 2000 ETF
IWM
$79.1B
$3.53M 0.78%
17,399
-126
-0.7% -$25.5K
MRK icon
41
Merck
MRK
$322B
$3.53M 0.78%
28,508
+19,316
+210% +$2.49M
BLK icon
42
Blackrock
BLK
$167B
$3.42M 0.76%
4,349
+135
+3% +$105K
WMT icon
43
Walmart Inc
WMT
$909B
$3.42M 0.76%
50,450
+5,169
+11% +$326K
AMGN icon
44
Amgen
AMGN
$209B
$3.27M 0.72%
10,466
+1,110
+12% +$326K
XLK icon
45
State Street Technology Select Sector SPDR ETF
XLK
$109B
$2.83M 0.63%
25,040
+300
+1% +$31.6K
LHX icon
46
L3Harris
LHX
$55.4B
$2.69M 0.6%
11,984
+11,965
+62,974% +$2.59M
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.63M 0.58%
6,465
-489
-7% -$200K
UNP icon
48
Union Pacific
UNP
$174B
$2.32M 0.51%
10,259
+775
+8% +$182K
SBUX icon
49
Starbucks
SBUX
$119B
$2.25M 0.5%
28,925
+1,099
+4% +$89.5K
PLTR icon
50
Palantir
PLTR
$295B
$2.1M 0.46%
+82,810
New +$1.86M

Similar funds

Trifecta Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Trifecta Capital Advisors held 434 positions worth $452M, up 9.9% from $411M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Trifecta Capital Advisors deployed $14.6M of net new capital in Q2 2024, opening 23 new positions and adding to 84 existing holdings. Its largest new stake was Palantir: 82,810 shares worth $2.1M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $2.47M trimmed.

  • Trifecta Capital Advisors's largest Q2 2024 buy was Palantir: 82,810 shares worth $2.1M.
  • Trifecta Capital Advisors added most to Meta Platforms (Facebook) in Q2 2024, an estimated $5.65M increase.
  • Trifecta Capital Advisors's biggest Q2 2024 reduction was Johnson & Johnson, cutting an estimated $2.47M.
  • Trifecta Capital Advisors fully exited lululemon athletica in Q2 2024, selling an estimated $1.48M.
  • Trifecta Capital Advisors's ten largest holdings make up 50% of its $452M portfolio in Q2 2024.
  • Trifecta Capital Advisors opened 23 new positions and closed 16 in Q2 2024.
  • Trifecta Capital Advisors's portfolio value rose 9.9% quarter-over-quarter to $452M.

Based on Trifecta Capital Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.